Amir Reichman
Amministratore Delegato presso SCINAI IMMUNOTHERAPEUTICS LTD.
Patrimonio netto: 66 720 $ in data 30/06/2024
Posizioni attive di Amir Reichman
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| SCINAI IMMUNOTHERAPEUTICS LTD. | Direttore/Membro del Consiglio | 02/03/2021 | - |
| Amministratore Delegato | 02/03/2021 | - |
Storia della carriera di Amir Reichman
Precedenti posizioni note di Amir Reichman
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
GlaxoSmithKline Pharmaceuticals SA (Belgium)
 GlaxoSmithKline Pharmaceuticals SA (Belgium) Pharmaceuticals: MajorHealth Technology GlaxoSmithKline Pharmaceuticals SA develops and manufactures pharmaceuticals and vaccines. The company is headquartered in Wavre, Belgium. | Corporate Officer/Principal | 01/09/2015 | 01/03/2021 |
| Novartis Vaccines & Diagnostics, Inc. (North Carolina) | Corporate Officer/Principal | 01/01/2011 | 01/01/2015 |
| NEURODERM LTD | Fondatore | 01/01/2003 | 01/01/2009 |
| Corporate Officer/Principal | 01/01/2003 | 01/01/2009 |
Formazione di Amir Reichman
| The Wharton School of the University of Pennsylvania | Masters Business Admin |
| Ben-Gurion University of the Negev | Undergraduate Degree |
Statistiche
Distribuzione geografica
| Israele | 4 |
| Stati Uniti | 3 |
| Belgio | 2 |
Posizioni
| Corporate Officer/Principal | 3 |
| Director/Board Member | 1 |
| Chief Executive Officer | 1 |
Settori
| Health Technology | 4 |
| Consumer Services | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| SCINAI IMMUNOTHERAPEUTICS LTD. | Health Technology |
| Aziende private | 3 |
|---|---|
GlaxoSmithKline Pharmaceuticals SA (Belgium)
GlaxoSmithKline Pharmaceuticals SA (Belgium) Pharmaceuticals: MajorHealth Technology GlaxoSmithKline Pharmaceuticals SA develops and manufactures pharmaceuticals and vaccines. The company is headquartered in Wavre, Belgium. | Health Technology |
| Novartis Vaccines & Diagnostics, Inc. (North Carolina) | |
NeuroDerm Ltd.
 NeuroDerm Ltd. BiotechnologyHealth Technology NeuroDerm Ltd. operates as a clinical-stage pharmaceutical company. It engages in the development of next-generation treatments for central nervous system disorders. The company was founded by Eliahu Heldman on March 18, 2003 and is headquartered in Rehovot, Israel. | Health Technology |
- Borsa valori
- Insiders
- Amir Reichman
- Esperienza
